137 related articles for article (PubMed ID: 34424219)
1. Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5
Feng H; Zhou H; Lu J; Zhang Q; Tang X; Shang Y
Aging (Albany NY); 2021 Aug; 13(16):20418-20437. PubMed ID: 34424219
[TBL] [Abstract][Full Text] [Related]
2. The effects of combined bromocriptine and Bu-shen-zhu-yun decoction on serum hormones, anxiety, and pregnancy in hyperprolactinemic infertility patients.
Feng H; Zhong Q; Zhou H; Jiang X; Ding Y
Ann Palliat Med; 2021 Dec; 10(12):12230-12243. PubMed ID: 35016475
[TBL] [Abstract][Full Text] [Related]
3. Bu-shen-zhu-yun decoction promotes synthesis and secretion of FSHβ and LHβ in anterior pituitary cells in vitro.
Jiang X; Zhou H; Shi M; Zhou B; Liu B; Yuan Y; Shan J; Xu J; Xie T
Biomed Pharmacother; 2018 Jun; 102():494-501. PubMed ID: 29579710
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Yisui Jiedu Recipe on JAK2-STAT5 signal transduction pathway in bone marrow hematopoietic cells from patients with myelodysplastic syndrome-refractory anemia].
Tian SL; Zhou YM; Huang T; Xue ZZ; He W
Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):185-9. PubMed ID: 18241656
[TBL] [Abstract][Full Text] [Related]
5. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
6. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
Zhao D; Ma G; Zhang X; He Y; Li M; Han X; Fu L; Dong XY; Nagy T; Zhao Q; Fu L; Dong JT
J Biol Chem; 2016 Jun; 291(24):12809-12820. PubMed ID: 27129249
[TBL] [Abstract][Full Text] [Related]
7. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
8. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
Qian L; Lopez V; Seo YA; Kelleher SL
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C369-77. PubMed ID: 19494234
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
10. Mutant prolactin receptor and familial hyperprolactinemia.
Newey PJ; Gorvin CM; Cleland SJ; Willberg CB; Bridge M; Azharuddin M; Drummond RS; van der Merwe PA; Klenerman P; Bountra C; Thakker RV
N Engl J Med; 2013 Nov; 369(21):2012-2020. PubMed ID: 24195502
[TBL] [Abstract][Full Text] [Related]
11. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
12. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
13. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
[TBL] [Abstract][Full Text] [Related]
15. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
16. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
17. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
18. d-Glucose and amino acid deficiency inhibits casein synthesis through JAK2/STAT5 and AMPK/mTOR signaling pathways in mammary epithelial cells of dairy cows.
Zhang MC; Zhao SG; Wang SS; Luo CC; Gao HN; Zheng N; Wang JQ
J Dairy Sci; 2018 Feb; 101(2):1737-1746. PubMed ID: 29248227
[TBL] [Abstract][Full Text] [Related]
19. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
Johnston AN; Bu W; Hein S; Garcia S; Camacho L; Xue L; Qin L; Nagi C; Hilsenbeck SG; Kapali J; Podsypanina K; Nangia J; Li Y
Breast Cancer Res; 2018 May; 20(1):42. PubMed ID: 29778097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
